Occupational exposure of platinum-based anti-cancer drugs: five-year monitoring of hair and environmental samples in a single hospital.

Anti-cancer drug Hair Hospital Inductively coupled plasma mass spectrometry Platinum

Journal

Journal of occupational medicine and toxicology (London, England)
ISSN: 1745-6673
Titre abrégé: J Occup Med Toxicol
Pays: England
ID NLM: 101245790

Informations de publication

Date de publication:
2020
Historique:
received: 20 11 2019
accepted: 03 09 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 3 10 2020
Statut: epublish

Résumé

Occupational exposure to chemotherapeutic agents in hospitals is a critical issue. Here, we focused on occupational exposure to platinum-based anti-cancer drugs (PDs) by evaluating platinum concentrations in hair and environmental workplace samples to monitor the risk among workers. Hospital workers who dealt with or without PDs, patients treated with PDs, and non-medical office workers outside the hospital donated hair samples and completed a questionnaire regarding their history of handling PDs, including any incidents. Hair samples were collected and surface wipe sampling was performed in July 2010 and April 2015, before and after moving to a new building and introducing a revised safety program in August 2010. Samples were analyzed by inductively coupled plasma-mass spectrometry. Platinum concentrations in hair from PDs-handling workers was significantly higher than in non-PDs-handling workers ( Platinum concentrations in hair are likely dependent on the frequency of handling PDs. Reduced environmental contamination from PDs did not influence platinum levels in hospital workers' hair. Continuous monitoring by measuring platinum concentrations in the environment and in hair would provide information regarding these issues.

Sections du résumé

BACKGROUND BACKGROUND
Occupational exposure to chemotherapeutic agents in hospitals is a critical issue. Here, we focused on occupational exposure to platinum-based anti-cancer drugs (PDs) by evaluating platinum concentrations in hair and environmental workplace samples to monitor the risk among workers.
METHODS METHODS
Hospital workers who dealt with or without PDs, patients treated with PDs, and non-medical office workers outside the hospital donated hair samples and completed a questionnaire regarding their history of handling PDs, including any incidents. Hair samples were collected and surface wipe sampling was performed in July 2010 and April 2015, before and after moving to a new building and introducing a revised safety program in August 2010. Samples were analyzed by inductively coupled plasma-mass spectrometry.
RESULTS RESULTS
Platinum concentrations in hair from PDs-handling workers was significantly higher than in non-PDs-handling workers (
CONCLUSION CONCLUSIONS
Platinum concentrations in hair are likely dependent on the frequency of handling PDs. Reduced environmental contamination from PDs did not influence platinum levels in hospital workers' hair. Continuous monitoring by measuring platinum concentrations in the environment and in hair would provide information regarding these issues.

Identifiants

pubmed: 33005211
doi: 10.1186/s12995-020-00280-1
pii: 280
pmc: PMC7523399
doi:

Types de publication

Journal Article

Langues

eng

Pagination

29

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

J Oncol Pharm Pract. 2005 Jun;11(2):69-78
pubmed: 16465719
J Occup Environ Med. 2014 Sep;56(9):901-10
pubmed: 25153300
Int Arch Occup Environ Health. 2007 Aug;80(8):689-99
pubmed: 17377802
Epidemiology. 2007 Jan;18(1):112-9
pubmed: 17099323
J Toxicol Environ Health A. 2012;75(13-15):893-908
pubmed: 22788375
Curr Oncol. 2015 Feb;22(1):e27-37
pubmed: 25684994
Int Arch Occup Environ Health. 1997;70(3):209-14
pubmed: 9298405
Am J Obstet Gynecol. 2012 Apr;206(4):327.e1-8
pubmed: 22304790
Anal Bioanal Chem. 2005 Oct;383(3):500-8
pubmed: 15947916
J Oncol Pharm Pract. 2011 Mar;17(1):29-38
pubmed: 20699333
Toxicol Lett. 2012 Aug 13;213(1):107-15
pubmed: 21477641
Clin Cancer Res. 2000 Apr;6(4):1205-18
pubmed: 10778943
J Oncol Pract. 2015 Jul;11(4):278-9
pubmed: 26036264
Sci Total Environ. 2011 Sep 15;409(20):4484-8
pubmed: 21784505
J Oncol Pharm Pract. 2014 Aug;20(4):278-87
pubmed: 23975555
Occup Environ Med. 2002 Sep;59(9):608-12
pubmed: 12205233
PLoS One. 2016 Jul 08;11(7):e0159052
pubmed: 27391697
J Trace Elem Med Biol. 2011 Jan;25 Suppl 1:S41-4
pubmed: 21177085

Auteurs

Ai Hori (A)

Department of Epidemiology and Prevention, National Center for Global Health and Medicine (NCGM), Tokyo, Japan.
Department of Global Public Health, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki 305-8577 Japan.

Mari Shimura (M)

Department of Intractable Diseases, NCGM, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655 Japan.

Yutaka Iida (Y)

Inorganic Analysis Laboratories, Toray Research Center, Inc., Otsu, Japan.

Kazuhiko Yamada (K)

Department of Surgery, Hospital, NCGM, Tokyo, Japan.

Kyoko Nohara (K)

Department of Surgery, Hospital, NCGM, Tokyo, Japan.

Takayuki Ichinose (T)

Inorganic Analysis Laboratories, Toray Research Center, Inc., Otsu, Japan.

Ai Yamashita (A)

Inorganic Analysis Laboratories, Toray Research Center, Inc., Otsu, Japan.

Junko Shirataki (J)

Inorganic Analysis Laboratories, Toray Research Center, Inc., Otsu, Japan.

Shotaro Hagiwara (S)

Division of Hematology, Internal Medicine, Hospital, NCGM, Tokyo, Japan.
Present address: Department of Hematology, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.

Classifications MeSH